Health · 1 view
Trial results show no survival benefit with the use of proton therapy in patients with advanced hepatocellular carcinoma
Initial results of the NRG Oncology NRG-GI003 clinical study comparing proton and photon therapy for patients with advanced hepatocellular carcinoma (HCC) indicate that proton therapy did not improve the primary objective of overall…
AI Summary
Initial results from the NRG Oncology NRG‑GI003 trial comparing proton versus photon therapy in advanced hepatocellular carcinoma patients showed no improvement in overall survival, the primary endpoint. At the interim analysis the study crossed a futility boundary and was released for reporting. Secondary outcomes, including progression‑free survival and local progression, also showed no benefit from proton therapy.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Brain tissue removed during surgery reveals potential way to curb inflammation linked to Alzheimer'sContinue reading
- Digital media health risks warrant global action to protect young people, experts argueContinue reading
- What does marathon training do to your body? A reporter becomes the test subjectContinue reading
- Health records from 68 adults link plant-based grocery support to lower blood pressure and weightContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow